查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1133471

全球输液袋市场-2022-2029

Global IV Bags Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 250 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

输液袋市场的增长是由癌症和神经系统疾病等各种疾病的患病率上升、越来越多地采用输液疗法来适当治疗疾病、增加老年人口以及活动带来的研究和开发推动的。

肠外营养疗法的普及预计将推动市场增长

癌症和心血管疾病等各种疾病的患病率上升预计将在预测期内提振市场。根据世界卫生组织 2022 年数据报告，每年有 4100 万人死于非传染性疾病。这种疾病包括癌症、糖尿病等。在这种情况下，紧急情况下需要肠外营养。恶性肿瘤、缺血性肠病、胃肠道疾病、克罗恩病和糖尿病并发症等疾病的发病率不断上升，这推动了人们对肠外营养的兴趣。对肠外营养疗法的需求不断增长，正在推动全球输液袋市场的发展。

此外，大公司正在应用他们的市场战略，例如新产品发布和与其他市场参与者的合作。例如，2022 年 1 月，ICU Medical 从 Smiths Group plc 收购了 Smiths Medical，将 Smiths Medical 注射器和流动输液设备、血管通路和重要护理产品添加到 ICU Medical 的产品组合中，打造了一家更强大、具有全球影响力的输液治疗领先公司得到了加强。同样在 2021 年 3 月，Fagron Sterile Services (FSS) 通过推出一个新平台来扩展其产品组合，该平台具有多种可用于静脉注射 (IV) 袋的展示。

输液袋中化学物质的洗脱阻碍了市场增长

但是，PVC 袋并不适合所有人的产品，例如血液製品。输液袋主要由聚氯乙烯（PVC）材料製成。由于 PVC 本质上是刚性的，因此添加增塑剂以获得所需的性能。由于这些增塑剂没有与 PVC 基体共价结合，因此它们很容易渗入周围的溶液中。经常报导从 PVC 袋中浸出和提取邻苯二甲酸二（2-乙基己酯）（DEHP），大部分 DEHP 用于储存和输送血液的地方，或用于亲脂性药物的肠内和肠外给药。使用营养补充剂的地方。这阻碍了市场增长。

COVID-19 影响分析

COVID-19 的出现对全球输液袋市场产生了相当大的影响。在大流行中，美国等发达国家经历了液体和液体袋的短缺，迫使医疗机构和提供者推迟对患者的护理或采取其他替代方案，从而导致患者护理的减少。 FDA 等公共卫生当局经常要求製造商提高生产能力以解决这些短缺问题。在大流行期间，美国各州的 COVID-19 病例将增加，对恢復期血浆的需求将猛增。此外，随着 COVID-19 患者数量的增加，对静脉输液的需求将增加。同时，主要公司扩大生产能力以满足市场需求。例如，2020 年 4 月，百特和费森尤斯承诺向需要治疗 COVID-19 患者的医院提供额外的物资，例如肾透析机。在此，我们提议将含有袋装乳酸透析液的预混透析液的产量提高 75%。百特还表示，它已经增加了许多其他用品的生产，例如迷你袋和药物输送系统。在大流行期间，输液袋经历了迅猛的市场增长。

全球输液袋市场报告将提供对大约 80 多个市场数据表、70 多个图表和 250 多个页面（大约）的访问。

内容

第一章市场研究方法和范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

  • 按类型：市场细分
  • 按材料：市场细分
  • 按规模：市场细分
  • 按应用：市场细分
  • 按最终用户：市场细分
  • 按地区：市场细分

第 4 章市场动态

  • 市场影响因素
    • 驱动程序
      • 感染增加
      • 老年人口增加
    • 限制
    • 用于静脉滴注的塑料袋中流出的化学物质的风险
    • 影响分析

第五章行业分析

  • 波特五力分析
  • 供应链分析
  • 监管分析
  • 定价分析
  • 未满足的需求分析

第 6 章 COVID-19 分析

  • COVID-19 的市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按类型

  • 单室
  • 多室

第 8 章按材料分类

  • 乙烯醋酸乙烯酯
  • 聚丙烯
  • 聚氯乙烯
  • 其他

第 9 章按大小划分

  • 0-250ml
  • 250-500ml
  • 500-1000ml

第 10 章按应用程序

  • 药物递送
  • 输血
  • 血液储存
  • 其他

第 11 章，最终用户

  • 医院
  • 水合设施/诊所
  • 家庭医疗
  • 其他

第 12 章按地区划分

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 13 章竞争格局

  • 主要发展和战略
  • 公司份额分析
  • 按治疗类型划分的基准

第 14 章公司简介

  • 百特
    • 公司概况
    • 治疗类型组合和描述
    • 主要亮点
    • 财务摘要
  • B. Braun Melsungen AG
  • Pfizer, Inc.
  • Fresenius Kabi AG
  • JW Life Science
  • RENOLIT
  • PolyCine GmbH
  • Sealed Air
  • ANGIPLAST PVT. LTD
  • Shanghai Solve Care Co Ltd.
  • Kraton Corporation
  • Jiangxi Sanxin Medtec Co., Ltd.

第 15 章全球输液袋市场-DataM

简介目录
Product Code: DMPH5857

Market Overview

IV Bags Market size was valued at US$ xx million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of 5% during the forecast period (2022-2029).

The IV bags are used to deliver different clinical nutritional fluids such as sodium chloride or other parenteral nutrition to the patient's body to treat a specific disease such as chronic diseases. The patient's IV fluids for specific purposes include medication administration, fluid, and electrolyte replacement and balance maintenance, blood or blood product delivery, and nutrient and nutritional supplement delivery.

Market Dynamics

The IV bags market growth is driven by the rise in prevalence of different diseases such as cancer, and neurological disorders rising adoption of IV therapy to take proper treatment of diseases, the increase in the geriatric population, and research and development activities.

The rising adoption of parenteral nutrition therapy is expected to drive the market growth

The rising prevalence of different diseases such as cancer and cardiovascular diseases is expected to boost the market over the forecast period. According to the WHO 2022 data report, due to non-communicable diseases 41 million people are killed each year. The disease includes cancers, diabetes, and others. In this case, parenteral nutrition is needed in an emergency case. The rising incidence of diseases such as malignancy, ischemic gut malady, gastrointestinal disorders, Crohn's disease, and diabetic intricacies is propelled interest in parenteral nutrition. Increasing demand for parenteral nutrition therapy drives the IV bags market worldwide.

In addition, the key players are applying their market strategies such as new product launching and collaboration with other market players. For instance, In January 2022, ICU Medical acquire Smiths Medical from Smiths Group plc, this acquisition of Smiths Medical syringe and ambulatory infusion devices, vascular access, and vital care products to the ICU Medical portfolio strengthen a leading infusion therapy company with a more strong worldwide reach. Also, in March 2021, Fagron Sterile Services (FSS) expanded its product portfolio by introducing a new platform with multiple presentations available for Intravenous (IV) Bags.

The leaching chemical from IV Bags will hamper the growth of the market

However, PVC bags are not suitable for everyone's formulations such as blood products. Mainly, Polyvinyl chloride (PVC) material is used for IV bags. PVC is not inherently flexible, plasticizers are added to achieve desirable properties. These plasticizers are not covalently bound to the PVC matrix and thus can easily leach into the surrounding solutions. The Leaching and extraction of di (2-ethylhexyl) phthalate (DEHP) from PVC bags have been reported often, with most DEHP found in bags utilized where blood is stored and delivered, or lipophilic drugs enteral and parenteral nutrition admixtures. This will hamper the market growth.

COVID-19 Impact Analysis

The appearance of COVID-19 considerably impacted the global IV bag market. In the pandemic, developed countries such as the United States have witnessed IV fluid and IV bag shortages, forcing healthcare facilities and providers to delay patient treatment or adopt other alternatives, resulting in a decrease in patient care. Public health authorities such as the FDA routinely request manufacturers to increase their ability to grow production capacity to address these shortages. In a pandemic, the United States is witness to a rapid rise in demand for convalescent plasma as COVID-19 cases increase in the states. The demand for IV fluid will increase with the increasing number of COVID-19 patients. On the other hand, the key players expanded their manufacturing production capabilities to meet the demand in the market. For instance, in April 2020, Baxter and Fresenius declared that they would deliver extra kidney dialysis equipment and other supplies to hospitals that require them for treating COVID-19 patients. In this, they provided a 75% increase in the production of premixed dialysate fluids with bagged lactate dialysate solution. Baxter also stated that it has increased the production of many other supplies, such as the mini-bag plus drug delivery system. The IV bags had positive market growth in the pandemic.

Segment Analysis

The multi-chamber IV bags segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The multi-chamber IV bag segment is expected to boost the market over the period of the forecast. Multi-chamber IV bags provide numerous benefits, including improved patient safety because they reduce handling and the risk of contamination. Patients can receive standard mixtures of fluids such as lipids, amino acids, or glucose. They have separate seals and can store more than one nutritional fluid. In April 2022, the article published in the Chinese Society for Parenteral and Enternal Nutrition, mentioned the advantages of Multi-chmaber IV bags for home and hospital use.

The multi-chamber bag preparation has a variety of specifications and has the characteristics of ready-to-use, strict quality standards, reasonable prescription, and other characteristics, which can decrease configuration and prescription errors, lower bloodstream infections, and meet the clinical nutritional needs of the patients. The key players offer the only multi-chamber IV bag product portfolio in the market. For instance, B. Braun offers multi-chamber IV bags such as 3-chamber IV bags for emulsion infusion for nutrition purposes and also offers dual chamber IV bags for the purpose of separate filling and storage of lipid emulsion until the mixing of the full solution just before administration to the patient. These bags are available in different sizes such as 50 ml, 100 ml, 500 ml, 1000 ml, and others.

Geographical Analysis

North America region holds the largest market share of the global IV bags market

North America dominates the market for IV bags and is expected to show a similar trend over the forecast period. It is estimated to hold a significant market size over the forecast period (2022-2029) owing to a rising elderly population with diseases such as cancer and respiratory diseases, an advanced healthcare system, and the presence of market players. Patients who are undergoing an operative process receive IVs that provide essential fluids like saline. To store these fluids requires IV bags.

The larger patient pool means more demand for IV bags in the region. In addition, the presence of competitors, acquisitions, and new product launches boosts the market growth in the North American region. For instance, in February 2022, B. Braun Medical Company received United States FDA approval to start operations at its new IV saline solution manufacturing facility in Florida, United States. It will address the shortage of IV fluids and is expected to manufacture 0.9% sodium chloride for injection.

Also in March 2021, Fagron Sterile Services US (FSS) expanded its product portfolio with a new platform - intravenous (IV) bags in the United States.

Competitive Landscape

The IV bags market is a moderately competitive presence of local as well as global companies. Some of the key players which are contributing to the growth of the market are Baxter, B. Braun Melsungen AG, Pfizer, Inc., Fresenius Kabi AG, JW Life Science, RENOLIT, PolyCine GmbH, Sealed Air, ANGIPLAST PVT. LTD, Shanghai Solve Care Co Ltd., Kraton Corporation, and Jiangxi Sanxin Medtec Co., Ltd. among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the IV bags market globally.

For instance,

  • In June 2022, Gufic Biosciences partnered with its French counterpart to manufacture new technology indigenously in India. The dual-chamber bags introduced by Gufic Biosciences were 2-Chamber IV Bags, made up of polypropylene (DEHP free) with a peelable aluminum foil allowing the storage of unstable drugs which require a reconstitution just before the administration to the patient.

Baxter Healthcare

Overview:

Baxter Healthcare is an American multinational healthcare company founded in 1940, headquartered in United States. It is provides the wide range of parenteral nutrition portfolio including vitamins and lipids, premix IV solutions, and pharmacy workflow management, labeling and compounding technology.

Treatment type Portfolio:

Baxter Sodium Chloride 0.9% IV Bags: It is available in variety of configurations and sizes such as 50mL, 100mL, 250mL, 500mL, and 1000mL Viaflex containers. These products are used for for intravenous administration. It is available in sodium chloride (0.9%), dextrose (5%) in water (D5W), and lactated ringers (LR).

The global IV bags market report would provide access to approximately 80+ market data tables, 70+ figures, and in the range of 250+ (approximate) pages.

Table of Contents

1. Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet By Type
  • 3.2. Market Snippet By Material
  • 3.3. Market Snippet By Size
  • 3.4. Market Snippet By Application
  • 3.5. Market Snippet By End User
  • 3.6. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The rising infectious disease
      • 4.1.1.2. The increasing geriatric population
    • 4.1.2. Restraints:
    • 4.1.3. Risk of leaching of chemicals from the plastic IV bags
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis
  • 5.4. Pricing Analysis
  • 5.5. Unmet Needs

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
    • 7.1.2. Market Attractiveness Index, By Type Segment
  • 7.2. Single Chamber*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Multi-Chamber

8. By Material

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Segment
    • 8.1.2. Market Attractiveness Index, By Material Segment
  • 8.2. Ethylene Vinyl Acetate*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Polypropylene
  • 8.4. Polyvinyl Chloride
  • 8.5. Others

9. By Size

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Size Segment
    • 9.1.2. Market Attractiveness Index, By Size Segment
  • 9.2. 0 - 250 ml*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. 250 - 500 ml
  • 9.4. 500 - 1000 ml

10. By Application

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
    • 10.1.2. Market Attractiveness Index, By Application Segment
  • 10.2. Deliver Medications*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Blood Transfusions
  • 10.4. Blood Storage
  • 10.5. Others

11. By End User

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.1.2. Market Attractiveness Index, By End User
  • 11.2. Hospitals*
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 11.3. Hydration Centers / Clinics
  • 11.4. Home Care Settings
  • 11.5. Others

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 12.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Size
    • 12.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 12.2.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.2.8.1. The U.S.
      • 12.2.8.2. Canada
      • 12.2.8.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 12.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Size
    • 12.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 12.3.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.3.8.1. Germany
      • 12.3.8.2. U.K.
      • 12.3.8.3. France
      • 12.3.8.4. Italy
      • 12.3.8.5. Spain
      • 12.3.8.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 12.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Size
    • 12.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 12.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.4.8.1. Brazil
      • 12.4.8.2. Argentina
      • 12.4.8.3. Rest of South America
  • 12.5. Asia Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 12.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Size
    • 12.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 12.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.5.8.1. China
      • 12.5.8.2. India
      • 12.5.8.3. Japan
      • 12.5.8.4. Australia
      • 12.5.8.5. Rest of Asia Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 12.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Size
    • 12.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 12.6.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution channel

13. Competitive Landscape

  • 13.1. Key Developments and Strategies
  • 13.2. Company Share Analysis
  • 13.3. Treatment type Benchmarking

14. Company Profiles

  • 14.1. Baxter*
    • 14.1.1. Company Overview
    • 14.1.2. Treatment type Portfolio and Description
    • 14.1.3. Key Highlights
    • 14.1.4. Financial Overview
  • 14.2. B. Braun Melsungen AG
  • 14.3. Pfizer, Inc.
  • 14.4. Fresenius Kabi AG
  • 14.5. JW Life Science
  • 14.6. RENOLIT
  • 14.7. PolyCine GmbH
  • 14.8. Sealed Air
  • 14.9. ANGIPLAST PVT. LTD
  • 14.10. Shanghai Solve Care Co Ltd.
  • 14.11. Kraton Corporation
  • 14.12. Jiangxi Sanxin Medtec Co., Ltd.

LIST NOT EXHAUSTIVE

15. Global IV Bags market- DataM

  • 15.1. Appendix
  • 15.2. About Us and Services
  • 15.3. Contact Us